Tislelizumab Combined with Thoracic Radiotherapy as Neoadjuvant Therapy for Resectable NSCLC: A single arm, phase II clinical study

The requested reference [747ba5f5bcc3b39520564cab92bf0f15f05bf603] no longer exists in our database. It has been replaced by the current reference: [1111b361c1952535516ae4e522ca686a8c66606a]

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: fe00f800b853617891d628ea645e585d5ca63011
First added on: Sep 12, 2026